Abajar, Baby Boy .
HRN: 23-34-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
AMPICILLIN 250MG (VIAL)
07/21/2023
07/28/2023
IVTT
200
Q12
PSNB
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes